Clinical trial · Observational
Prostatic Size Reduction Following of Leuprorelin Acetate
Prostatic Size Reduction Following the Administration of Leuprorelin Acetate in Localized Prostate Cancer Prior to Radiation Therapy. Pilot Study.
NCT06184464CI-TRIAL-00080621PROSTSIZErecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To determine the possible reduction in prostate size following the administration of Leuprelin prior to the application of radiotherapy.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Adenocarcinoma | Prostate Adenocarcinoma | ONTOLOGY_EXACT | 0.98 |
| Prostate Cancer Adenocarcinoma | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ACETATE LEUPRELINE | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- prostate patient
- description
- use of Leupreline
- interventionNames
- Other: ACETATE LEUPRELINE
Primary outcomes (1)
- measure
- prostate size change
- timeFrame
- at 2 months of leupreline
- description
- comparative size between pre and post Leupreline treatment
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 95 Years
Show eligibility criteria text
Inclusion Criteria: Man with Prostate positive biopsy. Able to Ssgned informed consent form. Need of hormonal treatment before start of radiotherapy Exclusion Criteria: Patients With prostate size of less than 20 cc at diagnosis. Patients With Positive lymph nodes or metastatic prostate cancer disease on imaging studies. Patients with Previous pelvic radiation therapy.
References
Publications (0)
Data not yet available
No reference posted for this study.